Product logins

Find logins to all Clarivate products below.


Scott Tatro

Vice President, Technology Consulting

Scott leads our dedicated Technology Consulting practice. Our practice offers a comprehensive range of resources and capabilities across multiple disciplines in our fields of expertise. We provide customers with the flexibility to combine their personalized and/or unique abilities to a robust catalog of services and data from Clarivate. Customers are enabled to optimize their technology platforms, streamline their processes, and make more informed decisions using both internal and external assets. Technology Consulting integrates across all Life Science & Healthcare Business Domains.

Prior to joining Clarivate, Scott most recently served as the Chief Customer Officer for Holon Solutions, a Healthcare Technology startup specializing in data integration and workflow optimization for ambulatory offices in the United States. Additionally, he spent 15 years at Oracle Cerner (previously Cerner Corporation) where he oversaw all product and go-to-market strategies for the company’s population health enterprise data warehouse, data acquisition, and longitudinal record portfolio items. Before that he had executive responsibilities for Cerner Technology Consulting services and helped establish the Application Management Services line of business focused on supporting client production systems.


arrow_forward
Get in touch with Scott

Related resources

为何更方便的给药方式并未获得支付方青睐 为何更方便的给药方式并未获得支付方青睐
Blog February 26, 2026
为何更方便的给药方式并未获得支付方青睐
应对完整回复函:科睿唯安解决方案如何帮助制药公司规划其获批路径 应对完整回复函:科睿唯安解决方案如何帮助制药公司规划其获批路径
Blog February 24, 2026
应对完整回复函:科睿唯安解决方案如何帮助制药公司规划其获批路径
FDA 临床试验 市场准入 最值得关注的药物 美国市场 药政法规
前进之路:收到 CRL 后该何去何从? 前进之路:收到 CRL 后该何去何从?
Blog February 24, 2026
前进之路:收到 CRL 后该何去何从?
FDA 临床试验 市场准入 最值得关注的药物 美国市场 药政法规
Relacorilant:当证据满足既定证据标准时 Relacorilant:当证据满足既定证据标准时
Blog February 24, 2026
Relacorilant:当证据满足既定证据标准时
FDA 临床试验 市场准入 最值得关注的药物 真实世界数据 美国市场 药政法规